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Chromosome positioning dynamics Nuclear myosin 1β-dependent repositioning of  chromosome territories occurs within 15 min- utes of serum starvation in human cells.
Abstract
Background: Radial chromosome positioning in interphase nuclei is nonrandom and can alter according to 
developmental, differentiation, proliferation, or disease status. However, it is not yet clear when and how chromosome 
repositioning is elicited.
Results: By investigating the positioning of all human chromosomes in primary fibroblasts that have left the 
proliferative cell cycle, we have demonstrated that in cells made quiescent by reversible growth arrest, chromosome 
positioning is altered considerably. We found that with the removal of serum from the culture medium, chromosome 
repositioning took less than 15 minutes, required energy and was inhibited by drugs affecting the polymerization of 
myosin and actin. We also observed that when cells became quiescent, the nuclear distribution of nuclear myosin 1β 
was dramatically different from that in proliferating cells. If we suppressed the expression of nuclear myosin 1β by using 
RNA-interference procedures, the movement of chromosomes after 15 minutes in low serum was inhibited. When high 
serum was restored to the serum-starved cultures, chromosome repositioning was evident only after 24 to 36 hours, 
and this coincided with a return to a proliferating distribution of nuclear myosin 1β.
Conclusions: These findings demonstrate that genome organization in interphase nuclei is altered considerably when 
cells leave the proliferative cell cycle and that repositioning of chromosomes relies on efficient functioning of an active 
nuclear motor complex that contains nuclear myosin 1β.
Background
Within interphase nuclei, individual chromosomes are
organized within their own nuclear space, known as
chromosome territories [1,2]. These interphase chromo-
some territories are organized in a nonrandom manner in
the nuclei of human cells and cells from other species [3].
Chromosomes in different species are positioned radially,
according to either their gene density [4-9] or their size
[10-12] or both [11,13-16]. The nuclear microenviron-
ment within which a chromosome is located could affect
its gene regulation, and it has been proposed that whole
chromosomes or regions of chromosomes are shifted
around the nucleus to control gene expression [17,18].
Active genes appear to come together in a common
nuclear space, possibly to be co-transcribed [19-21]. This
fits with the increasing number of observations made of
chromosome loops, containing active areas of the
genome, coming away from the main body of the chro-
mosome territory, such as regions containing FLNA on
the X chromosome [22]; major histocompatibility com-
plex (MHC) genes [23], specific genes on chromosome 11
[24]; β- globin-like genes [25], epidermal differentiation
complex genes [26], specific genes within the Hox B clus-
ter [27,28], and genes inducing porcine stem cell differen-
tiation into adipocytes [29]. Chromatin looping is
apparently associated with gene expression, because inhi-
bition of RNA polymerase II transcription affects the out-
ward movement of these chromosome loops [30].
Repositioning of whole chromosome territories has
been observed in erythroid differentiation [25], adipo-
genesis [31], T-cell differentiation [32], porcine sper-
matogenesis [33], and after hormonal stimulus [34]. Even
more studies revealed genomic loci being repositioned
during differentiation (see [35], for comprehensive
* Correspondence: joanna.bridger@brunel.ac.uk
1 Centre for Cell and Chromosome Biology, Division of Biosciences, School of 
Health Sciences and Social Care, Brunel University, Kingston Lane, Uxbridge, 
UB8 3PH, UKMehta et al. Genome Biology 2010, 11:R5
http://genomebiology.com/2010/11/1/R5
Page 2 of 17
review). We demonstrated previously that interphase
chromosomes occupy alternative nuclear positions when
proliferating cells become quiescent or senescent [5,7,9].
For example, chromosomes 13 and 18 move from a
peripheral nuclear location to an internal nuclear loca-
tion in serum-starved or senescent fibroblast cells [5,9].
From these early studies, it was not clear how other chro-
mosomes behaved after induction of growth arrest, and
so we have now positioned all human chromosomes in
cells made quiescent by serum starvation. We found that
just less than half of the chromosomes alter their nuclear
location. The ability to control, temporally, the entry of
cells to quiescence through serum starvation allows the
determination of a response time of nuclear architecture
to the change in environment. In this study, we demon-
strate that chromosome repositioning in interphase
nuclei occurs within 15 minutes.
The presence of actin [36] and myosin [37-41] have
been reported in nuclei, and an increasing body of evi-
dence suggests that they cooperate to form a nuclear
myosin-actin motor [42]. Actin and myosin have been
shown to be involved in the intranuclear movement of
chromosomal regions [43,44] and whole chromosomes
[34]. Further, nuclear actin and myosin are involved in
RNA polymerase I transcription [37,40], RNA poly-
merase II transcription [37-41], and RNA polymerase III
transcription [45]. In a model put forward by Hoffman
and colleagues [42], myosin I could bind through its tail
to the nuclear entity that requires movement, with actin
binding to the globular head of the nuclear myosin I mol-
ecule. This nuclear motor would then translocate the
nuclear entity along highly dynamic tracks of nuclear
actin [42]. In this study, we demonstrated that the rapid
movement of chromosome territories in response to
serum deprivation is dependent on the function of both
actin and myosin, probably nuclear myosin 1β.
Results
Interphase chromosome positioning in proliferating and 
nonproliferating cells
To determine the nuclear location of specific chromo-
somes, human dermal fibroblasts (HDFs) were harvested
and fixed for standard 2D-fluorescence in situ hybridiza-
tion (FISH). Representative images of chromosome terri-
tories in proliferating cells are displayed in Figure 1a-d.
Digital images were subjected to erosion analysis [4-
6,8,9], whereby the images of 4',6-diamidino-2-phenylin-
dole (DAPI)-stained flattened nuclei are divided into five
concentric shells of equal area, and the intensity of the
DAPI signal and probe signal is measured in each shell.
The chromosome signal is then normalized by dividing it
by the percentage of DAPI signal. The data for each chro-
mosome are then plotted as a histogram with error bars,
with the x-axis displaying the nuclear shells from 1 to 5,
representing the nuclear periphery to the nuclear interior,
respectively (Figure 1e-h).
In young proliferating fibroblasts, interphase chromo-
somes are positioned nonrandomly in a radial pattern
within nuclei [3]. In our 2D studies, we consistently found
gene-poor chromosomes, such as chromosomes X, 13,
and 18, located at the nuclear periphery [5,9], which fits
with their having more lamina-associated domains than
gene-poor chromosomes (see [46]). In this study, we
recapitulated the interphase chromosome positioning
with our present cultures and demonstrated that these
chromosomes are located at the nuclear periphery in
young proliferating cells (Figure 1b-d, f-h). Proliferating
cells within the primary cultures were identified by using
the proliferative marker, anti-pKi-67, which is distributed
in a number of different patterns within proliferating
human fibroblasts [47]. Its distribution is mainly nucleo-
lar and is shown in red (Figure 1a-d). Figure 1a and e
demonstrate the nuclear location of chromosome 10,
unlike chromosomes 13, 18, and X it is found in an inter-
mediate position in proliferating fibroblasts. The relative
interphase positions of chromosomes 10 and X have been
confirmed in 3D-FISH analyses (Figure 1i-k), whereby
HDFs were fixed to preserve their three-dimensionality
with 4% paraformaldehyde and subjected to 3D-FISH
[48]. Measurements in micrometers from the geometric
center the chromosome territories to the nearest nuclear
periphery, as determined by the DAPI staining, were
taken in at least 20 nuclei. The data were not normalized
for size measurements, so that actual measurements in
micrometers can be seen. However, all data were normal-
ized by a size measurement, and this not does alter the
relative positioning of the chromosomes.
W e  h a v e  e v i d e n c e  f r o m  p r i o r  s t u d i e s  t h a t  c h r o m o -
somes such as chromosomes 13 [9] and 18 [5,9] alter their
nuclear position when primary fibroblasts exit the prolif-
erative cell cycle and that chromosome X remains at the
nuclear periphery [9]. However, this is only two chromo-
somes of 24, and so to determine which other chromo-
somes reposition after cell-cycle exit into quiescence
(G0), elicited through serum removal, we positioned all
human chromosomes in G0 cells (Figures 2 and 3).
T o make cells quiescent, young, HDFs were grown in
10% NCS for 48 hours, and then the cells were washed
twice with serum-free medium and placed in 0.5% NCS
medium for 168 hours (7 days). However, when the posi-
tioning analysis was performed on the quiescent nuclei,
we found that certain chromosomes were in very differ-
ent positions from those in which they were found in pro-
liferating nuclei, that is, chromosomes 1, 6, 8, 10, 11, 12,
13, 15, 18, and 20 (Table 1).
The data demonstrated in Figure 3 and Table 1 reveal
that a number of chromosomes alter their nuclear posi-
tions when cells become quiescent; as shown before, bothMehta et al. Genome Biology 2010, 11:R5
http://genomebiology.com/2010/11/1/R5
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Chromosome positioning in proliferating interphase nuclei
Figure 1 Chromosome positioning in proliferating interphase nuclei. Proliferating human dermal fibroblasts (HDFs) cultures were subjected to 
2D- or 3D-fluorescence in situ hybridization (FISH) to delineate and analyze the nuclear location of chromosomes 10, 13, 18, and X. In panels (a-d), the 
chromosome territories are revealed in green with a single chromosome territory for chromosome X, because the HDFs are male in origin. The red 
antibody staining is the nuclear distribution of the proliferative marker anti-pKi-67, the presence of which denotes a cell in the proliferative cell cycle. 
DAPI (4',6-diamidino-2-phenylindole) in blue is a DNA intercalator dye and reveals the nuclear DNA. Scale bar = 10 μm. The histograms in panels (e-
h) display the distribution of the chromosome signal in 50 to 70 nuclei for each chromosome for 2D FISH, as analyzed with erosion analysis. This anal-
ysis divides each nucleus into five concentric shells of equal area, with shell 1 being the most peripheral shell, and shell 5 being the most interior shell 
[4-6,9]. The percentage of chromosome signal measured in each shell was divided by the percentage of DAPI signal in that shell. Bars represent the 
mean normalized proportion (percentage) of chromosome signal for each human chromosome. Error bars represent the standard error of the mean 
(SEM). Panels i and j display 3D projections of 0.2-μm optical sections through 3D preserved nuclei subjected to 3D-FISH and imaged with confocal 
laser scanning microscopy. The chromosome territories are displayed in red, and proliferating cells also were selected with positive anti-pKi-67 stain-
ing (not shown in reconstruction). Scale bar = 10 μm. The line graph in panel (k) displays a frequency distribution of micrometers from the geometric 
center of the chromosome territories to the nearest nuclear periphery, as defined by DAPI staining. Images for 20 nuclei were analyzed.
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chromosomes 13 and 18 move from a peripheral nuclear
location to an interior location (Figure 3m and r). Chro-
mosome 10 is one of a number of chromosomes that
move from an intermediate nuclear location to the
nuclear periphery (Figure 3j, Table 1), whereas chromo-
s o m e  X  d o e s  n o t  c h a n g e  i t s  l o c a t i o n  a t  t h e  n u c l e a r
periphery (Figure 3w), and chromosomes such as 17 and
19 do not change their interior location (Figure 3q and s,
respectively).
It certainly appears that the chromosome positioning in
quiescent G0 cells is correlated with size. However, it is
not clear why a repositioning of chromosomes occurs
after serum removal and when and how it is elicited.
The movement of chromosomes when normal fibroblasts 
exit the cell cycle is rapid, active, and requires myosin and 
actin
To determine when the genome is reorganized on exit
from the cell cycle and the speed of the response to the
removal of growth factors, we took actively proliferating
young cultures of primary HDFs and replaced 10% NCS
medium with 0.5% NCS medium. Samples were taken at
0, 5, 10, 15, and 30 minutes after serum starvation for fix-
ation, and chromosome position in interphase was deter-
mined with 2D-FISH and erosion analysis (Figure 4 and
Additional file 1). Chromosomes 13 and 18 relocated
from the nuclear periphery to the nuclear interior within
15 minutes (Figure 4h and l), with an intermediate-type
nuclear positioning visible in the intervening time points
(5 and 10 minutes; Figure 4f, g, j, and k). In addition,
chromosome 10 moved from an intermediate location to
a peripheral location in the same time window (15 min-
utes; Figure 4d). Chromosome X did not relocalize at all,
as was reported previously [9] (Figure 4m-o), apart from
some slight difference at 15 minutes (Figure 4p).
In a previous study, we demonstrated that relocation of
chromosome 18 from the nuclear interior in G0 cells to
the nuclear periphery in serum-restimulated cells took
30+ hours and appeared to require cells to rebuild their
nuclear architecture after a mitotic division [5]. We
Chromosome positioning in quiescent interphase nuclei
Figure 2 Chromosome positioning in quiescent interphase nuclei. Representative images displaying nuclei prepared for fluorescence in situ hy-
bridization (2D-FISH), with whole-chromosome painting probes (green), and nuclear DNA is counterstained with 4',6-diamidino-2-phenylindole (DA-
PI) (blue). The cells were subjected to indirect immunofluorescence with anti-pKi-67 antibodies, and negative cells were selected. Cells were placed 
in low serum (0.5%) for 7 days, before fixation with methanol:acetic acid (3:1). The numbers (or letters) on the left side of each panel indicate the chro-
mosome that has been hybridized. Scale bar = 10 μm.Mehta et al. Genome Biology 2010, 11:R5
http://genomebiology.com/2010/11/1/R5
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Analysis of radial chromosome positioning in quiescent cell nuclei
Figure 3 Analysis of radial chromosome positioning in quiescent cell nuclei. Histograms displaying chromosome positions in primary human 
quiescent fibroblast nuclei. The 50 to 70 nuclei per chromosome were subjected to erosion analysis, which divides each nucleus into five concentric 
shells of equal area, with shell 1 being the most peripheral shell, and shell 5 being the most interior shell [4-6,9]. The percentage of chromosome signal 
measured in each shell was divided by the percentage of 4',6-diamidino-2-phenylindole (DAPI) signal in that shell. Bars represent the mean normalized 
proportion (percentage) of chromosome signal for each human chromosome. Error bars represent the standard error of mean (SEM).
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showed here that the same is true for chromosome 10,
with a return to an intermediate nuclear location 24 to 36
hours after restimulation of G0 cells with 10% NCS (Fig-
ure 5d-f). We again showed that chromosome 18 requires
similar times to return to the nuclear periphery (that is,
36 hours; Figure 5l). Although chromosome X remains at
the nuclear periphery, a slight change in the distribution
of chromosome X occurs at 32 to 36 hours (Figure 5q-r).
From these data, it seems that a rapid response to the
removal of growth factors reorganizes the whole genome
within the interphase nucleus, and this reorganization is
corrected in proliferating cells only after 24+ hours in
high serum, presumably after the cells have passed
through mitosis, as indicated by the peak of mitotic cells
at 24 to 36 hours after serum restimulation (0 hours,
none; 8 hours, none; 24 hours, 0.3%; 32 hours, 2.6%; and
36 hours, 1.2%).
Such rapid movement of large regions of the genome in
response to low serum implies an active process, perhaps
requiring ATP/GTP. When inhibitors of ATPase and/or
GTPase, ouabain, and AG10, were incubated with prolif-
erating cell cultures in combination with low serum,
chromosome 10 did not change nuclear location (Figure
6a-d, and see Additional file 3). The relocation to the
nuclear interior of chromosome 18 territories after incu-
bation of cells in low serum also was perturbed by these
Table 1: The position of all chromosome territories in primary human dermal fibroblasts as determined by 2D FISH, image 
acquisition, and erosion analysis
Chromosome by size Proliferating
HDFs
Quiescent
HDFs
1 IMb P
2 Pb P
3 Pd P
4 Pcd Pc
5 IMd IM
6 IMb P
7 P^ P
X Pab Pc
8 IMb P
9 Pd P
10 IMd P
11 IMd P
12 Pb I
13 Pa Ic
14 Ib I
15 Pb I
16 Ib I
17 Ib I
18 Pac Iac
19 Ia Ia
20 Id IM
22 Ib I
21 Ib I
Y I^ I
This table summarizes the locations of all the chromosomes in quiescent and proliferating nuclei of human dermal fibroblasts (HDFs). The 
positions of chromosomes shown without a symbol have been determined for this study. aData derived from [5]. bData derived from [4]. cData 
derived from [9]. dData derived from [7].Mehta et al. Genome Biology 2010, 11:R5
http://genomebiology.com/2010/11/1/R5
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inhibitors (Figure 6a-d). The control chromosome, chro-
mosome X, remained at the nuclear periphery (Figure 6
and Additional file 3). Because other studies suggest that
nuclear motors move genomic regions around the
nucleus by actin and/or myosin [42,44] we decided to use
inhibitors of actin and myosin polymerization to attempt
to block any chromosome movement elicited by these
nuclear motors when serum was removed. Latrunculin A,
an inhibitor of actin polymerization, inhibited the move-
ment of both chromosomes 10 and 18 when cells were
placed in low serum (Figure 7a and Additional file 3). In
contrast, phalloidin oleate, another inhibitor of actin
polymerization did not prevent relocalization of either
c h r o m o s o m e  1 0  o r  1 8 ,  w h e n  c e l l s  w e r e  p l a c e d  i n  l o w
serum (Figure 7b and Additional file 3). However, two
inhibitors of myosin polymerization (BDM) and function
Rapid repositioning of chromosomes after removal of serum
Figure 4 Rapid repositioning of chromosomes after removal of serum. Chromosomes move rapidly in proliferating cells placed in low serum. 
The nuclear locations of human chromosomes 10 (a-d), 13 (e-h), 18 (i-l), and X (m-p) were analyzed in normal fibroblast cell nuclei fixed for 2D-FISH 
(fluorescence in situ hybridization) after incubation in medium containing low serum (0.5%) for 0, 5, 10, and 15 minutes. The filled-in squares indicate 
significance difference (P < 0.05) when compared with control proliferating fibroblast cell nuclei.
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Restoration of proliferative chromosome position after restimulation of G0 cells
Figure 5 Restoration of proliferative chromosome position after restimulation of G0 cells. The relocation of chromosomes to their proliferative 
nuclear location takes 24+ hours for chromosome 10 and 36 hours for chromosome 18. Proliferating cells (a, g, m) were placed in low serum (0.5%) 
for 7 days (b, h, n) and then restimulated to enter the proliferative cell cycle with the readdition of high serum. Samples were taken at 8 hours (c, i, o), 
24 hours (d, j, p), 32 hours (e, k, q), and 36 hours (f, l, r) after restimulation. The graphs display the normalized distribution of chromosome signal in 
each of the five shells. Shell 1 is the nuclear periphery, and shell 5 is the innermost region of the nucleus. The solid squares represent a significant 
difference (P < 0.05) for that shell when compared with the equivalent shell for the time 0 data (G0 data) for the erosion analysis.
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(Jasplakinolide; also affects actin polymerization) did
inhibit movements of both these chromosomes upon
serum removal (Figure 7c, d, and Additional file 3). Figure
7e provides a comparison for the rapid change in chro-
mosome position when no inhibitors are used. These data
imply that rapid chromosome movement observed in
cells as they respond to removal of growth factors is due
to an energy-driven process involving a nuclear
actin:myosin motor function.
Nuclear myosin 1β is required for chromosome territory 
repositioning in HDFs placed in low serum
I n  a n  e f f o r t  t o  e l u c i d a t e  w h i c h  m y o s i n  i s o f o r m  w a s
involved in chromosome movement after serum removal
in culture, we used suppression by RNA interference with
small interfering RNAs (siRNAs). An siRNA pool for the
gene MYO1C was selected because it encodes for a cyto-
plasmic myosin 1C and the nuclear isoform nuclear myo-
sin 1β, a major candidate myosin for chromatin
relocation [39,49]. mRNA analysis had revealed insuffi-
cient differences in sequence for suppression of myosin
1β alone (data not shown). With a double transfection of
the siRNA, we observed 93% of cells displaying no
nuclear myosin staining at all (Figure 8k, q, and s) but still
with some cytoplasmic staining, whereas in the control
cells and the cells transfected with the control construct,
>95% of cells displayed a nuclear distribution of anti-
nuclear myosin 1β, which was distributed in proliferating
cells as accumulations at the inner nuclear envelope, the
nucleoli, and throughout the cytoplasm (Figure 8g-j, m-
p). These numbers did not change significantly after
serum removal for 15 minutes, as per the chromosome-
movement assay (data not shown).
After siRNA suppression of nuclear myosin, the chro-
mosome-movement assay was repeated by placing the
double-transfected cells into low serum for 15 minutes.
The graphs in Figure 9 show that chromosomes 10, 18,
and X behave as expected after removal of serum in the
control cells (Figure 9a-f) and in the cells transfected with
the control construct (Figure 9g-l), with chromosome 10
becoming more peripheral, chromosome 18 becoming
more interior, and chromosome X remaining at the
nuclear periphery. However, in the cells that had been
transfected with MYO1C-targeting siRNA, chromosome
movement was much less dramatic, with the chromo-
Chromosome repositioning requires energy
Figure 6 Chromosome repositioning requires energy. The relocation of human chromosomes 10 and 18 after incubation in low serum is energy 
dependent. The nuclear location of human chromosomes 10, 18, and X in were determined in normal human proliferating cell nuclei treated with 
ouabain (ATPase inhibitor) (a), AG10 (GTPase inhibitor) (b), or a combination of both (c) before and during incubation in low serum for 15 minutes. 
Normal control analysis data without any treatment is displayed in (d). The error bars show the standard error of the mean. The stars indicate a signif-
icant difference (P < 0.05) from cells treated only with the inhibitor.
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somes still residing in similar nuclear compartments
before and after the serum removal (Figure 9m-r).
The distribution of the nuclear myosin 1β is very inter-
esting in these cells, because it gives a nuclear envelope
distribution, a nucleolar distribution, and a nucleoplas-
mic distribution (Figure 10a-c). These distributions,
although revealing, are not so surprising, because nuclear
myosin has a binding affinity for the integral nuclear
membrane protein emerin [50] and is involved in RNA
polymerase I transcription [37,40,51]. The distribution in
quiescent cells is quite different, with large aggregates of
NM1β within the nucleoplasm and is missing from the
nuclear envelope and nucleoli. This distribution is similar
to that observed in senescent human dermal fibroblasts
(Mehta, Kill, and Bridger, unpublished data). With
respect to chromosome movement back to a proliferating
position after incubation in low serum, we showed that it
does not occur until 24 to 36 hours after repeated addi-
tion of serum to a quiescent culture (Figure 5) [5]. Corre-
lating with this is the rebuilding of daughter nuclei after
mitosis and the return of a proliferating distribution of
NM1β to the nuclear envelope, nucleoli, and nucleoplasm
(Figure 10g, j, p).
Discussion
This study completes the nuclear positioning of all 24
chromosomes in quiescent (serum-starved) normal pri-
mary HDFs, as assessed with 2D-FISH and erosion analy-
sis, with a number of chromosomal positions confirmed
in 3D-preserved nuclei. This study, which was performed
Chromosome repositioning requires nuclear myosin and actin
Figure 7 Chromosome repositioning requires nuclear myosin and actin. The relocation of human chromosomes 10 and 18 after incubation in 
low serum is myosin and actin dependent. The nuclear locations of chromosomes 10, 18, and X were determined in normal human proliferating cell 
nuclei treated with latrunculin A and phalloidin oleate (inhibitors of actin polymerisation) (a, b) and BDM and jasplakinolide (inhibitors of myosin po-
lymerization) (c, d) before and during incubation in low serum for 15 minutes. The error bars show the standard error of the mean. The stars indicate 
a significant difference (P < 0.05) from cells treated only with the inhibitor. Normal control analysis data without any treatment is displayed in (e).
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on similar cell cultures and in the same way as previous
studies, highlighted that some considerable difference
exists in chromosomal nuclear locations between prolif-
erating and quiescent cells. This difference cannot be due
to change in nuclear size or shape, because some chromo-
somes move toward the nuclear interior, some, to the
nuclear periphery, and some do not alter their location at
all; no significant difference is found between nuclear
shape and size before and after 15 minutes in low serum
(data not shown). Some suggestion exists of a size-corre-
lated distribution in quiescent cells (Table 1), with large
chromosomes toward the nuclear periphery, and small
chromosomes toward the nuclear interior. These results
also confirm the data previously presented, whereby
small chromosomes 13 and 18 had differential nuclear
locations with respect to proliferating and nonproliferat-
ing cells [5,9].
How and when the alterations to chromosome posi-
tioning occur are two fundamental questions in under-
standing the role of genome organization in cell cycle-
related events. The genome is probably anchored and
influenced through a number of interactions with nuclear
architecture [52,53], and so any signalled alterations/
modifications to these structures could enable a reorgani-
zation of the position of chromosome territories. We
know that when cells are made quiescent (for 7 days) and
are restimulated to enter the cell cycle by the repeated
addition of serum, chromosome 18 is not relocated back
to the nuclear periphery until the cells have been through
mitosis [5].
The question remained open as to when chromosomes
were repositioned after serum removal. We found that
repositioning of chromosomes was very rapid and com-
plete by 15 minutes. The types of repositioning (a) requir-
ing a rebuilding of the nucleus after mitosis, and (b) the
rapid response without a nuclear envelope breakdown,
imply that these processes follow different pathways and
mechanisms, and the latter is consistent with an energy-
dependent mechanism. This rapid movement of chromo-
somes after growth factor removal may be elicited
through a nuclear motor such as the actin/myosin motor-
complex, containing nuclear actin and nuclear myosin I,
previously shown to be involved in intranuclear move-
ments of chromatin [42-44]. This hypothesis was sup-
ported by experiments using inhibitors of ATPase and
GTPase, as well as inhibitors of actin and myosin polym-
erization. The actin polymerization inhibitor phalloidin
oleate did not inhibit chromosome movement on
removal of high serum. This is important because phal-
loidin has been shown not to bind to nuclear actin unless
the cells are treated with DMSO [54], which we had not
done.
These data support other literature describing nuclear
motors being involved in chromatin behavior [44]. These
drugs have an effect on a broad range of myosins, and so
we wanted to assess whether specific myosins were
involved; thus we used an siRNA sequence that success-
fully suppressed the levels of nuclear myosin 1β, as shown
by indirect immunofluorescence. This is the only nuclear
myosin that would have been affected, but we cannot rule
Suppression of nuclear myosin expression by short interference RNAs (siRNAs)
Figure 8 Suppression of nuclear myosin expression by short interference RNAs (siRNAs). Normal human dermal fibroblasts (HDFs) were trans-
fected with negative control or MYO1C targeting siRNA (double transfection) and samples for immunofluorescence staining and 2D-FISH (fluores-
cence in situ hybridization) were fixed 48 hours after the final transfection. Representative images of nuclei stained for anti-NMIβ (red) in control (g, h, 
m, n) cells transfected with negative control siRNA (i, j, o, p) and in cells transfected with MYO1C siRNA (k, l, q, r) after 0 and 15 minutes of serum 
starvation are displayed. The percentage of nuclei that are positive for NM1β in controls, in cells transfected with negative control siRNA, and in cells 
transfected with MYO1C siRNA are displayed in the adjacent table (s).
(b) (c) (d) (e) (f)
(g) (h) (i) (j) (k) (l)
(m) (n) (o) (p) (q) (r)
Immunofluoroscence staining for nuclear myosin1 beta
Column1 %ofNMIβ positive nuclei
Control 0 mins 99.3
Control 15 mins 99.6
NC 0 mins 99.1
NC 15 mins 99.6
Myo1C 0 mins 6.9
Myo1C 15 mins 5.4
S
(a)Mehta et al. Genome Biology 2010, 11:R5
http://genomebiology.com/2010/11/1/R5
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out that other myosins located within the cytoplasm
(such as myosin 1A and 1C), which may be suppressed as
well, could have a long-range interaction with chromatin,
through the nuclear envelope, possibly through nesprins
and SUN domain proteins [55,56].
However, the distribution of nuclear myosin 1β that we
observe in proliferating cells correlates with its properties
and functions, as described in the literature, and impli-
cates the nuclear envelope in chromosome/chromatin
movement. In previous studies, we analyzed chromo-
some position in cells that have defects of the nuclear
lamina, through mutations in nuclear lamin A or emerin,
both nuclear envelope proteins. These cells displayed a
nonproliferating distribution of chromosomes even
though they were proliferating [9,57]. The behavior of
nuclear motor proteins in these cells must be addressed.
Further, the distribution of NM1β from aggregates in qui-
escent cells to the nuclear envelope, nucleoli, and nucleo-
plasm is not observed until more than 24 hours after
serum readdition, which correlated with when specific
chromosomes become relocated from their quiescent
position to their proliferating location.
Conclusions
We demonstrated that some chromosomes occupy differ-
ent nuclear compartments in proliferating and serum-
starved quiescent cells. Most interestingly, this reposi-
tioning of chromosomes is very rapid, taking less than 15
minutes, and requires energy and active actin and myosin
function. The myosin involved could be nuclear myosin
1β, which has dramatically different distribution in quies-
cent nuclei as compared with proliferating cell nuclei.
Chromosome repositioning is inhibited by short interference RNA (siRNA) that suppresses nuclear myosin1β
Figure 9 Chromosome repositioning is inhibited by short interference RNA (siRNA) that suppresses nuclear myosin1β. Chromosome posi-
tioning was determined with 2D-FISH (fluorescence in situ hybridization) and erosion analysis, and the normalized position data plotted as histograms 
in control cells, in cells transfected with the negative control, and in cells transfected with the MYO1C siRNA construct. In control human dermal fibro-
blasts (HDFs) and in HDFs transfected with negative control, siRNA chromosome 10 is repositioned from an intermediate nuclear location (a and g, 
respectively) to the nuclear periphery (d, j) after 15 minutes of incubation in low serum. Chromosome 18 territories, conversely, are repositioned 
from the nuclear periphery (b, h) to the nuclear interior (e, k) after 15 minutes of incubation in low serum in control HDFs and in HDFs transfected 
with negative control siRNA. In HDFs transfected with the MYO1C siRNA construct, chromosomes 10 (m, p) and 18 (n, q) do not show repositioning 
after 15 minutes of incubation in low serum. Chromosome X remains at the nuclear periphery at all times (c, f, i, l, o, r). Unpaired, unequal variances 
two-tailed Students t tests were performed to assess statistical differences. The solid squares indicate a significant difference (P < 0.05) from cells not 
incubated in, and the solid circles indicate a significant difference (P < 0.05) from control HDFs.
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Materials and methods
Cell culture
Human dermal fibroblasts (HDFs), 2DD [58] were grown
in Dulbecco's Modified Eagles Medium (DMEM) con-
taining 10% newborn calf serum (vol/vol NCS), glu-
tamine, and antibiotics, at 37°C. Cells were passaged
twice a week and seeded at a density of 3 × 103/cm2. Cells
were made quiescent by incubation in 10% NCS DMEM
for 2 days, washing in serum-free medium, followed by
incubation in DMEM containing 0.5% NCS (vol/vol) for 7
days.
Inhibitors of ATPase, GTPase, myosin, and actin 
polymerization
To inhibit the activity of ATPase or GTPase, cells were
treated with 100 μmol/L ouabain (Calbiochem-Novabio-
chem, Beeston, Nottingham, UK) for 30 minutes [59] or
with 100 μmol/L AG10 (Calbiochem) for 20 or 30 min-
utes before serum withdrawal [60,61], respectively. To
inhibit the polymerization of actin, cells were treated
with 1 μmol/L either Latrunculin A (Calbiochem) [62,63]
or phalloidin oleate (Calbiochem) [64] for 30 minutes.
Myosin polymerization was inhibited by treating cells
Anti-nuclear myosin 1b (NM1β) staining patterns in proliferating cells, quiescent cells, and after restimulation
Figure 10 Anti-nuclear myosin 1b (NM1β) staining patterns in proliferating cells, quiescent cells, and after restimulation. Normal 2DD hu-
man dermal fibroblasts (HDFs) were serum starved for 7 days to induce quiescence. The cells were then restimulated with fresh serum, and samples 
were collected at 0, 24, 36 and 48 hours after serum restoration. Samples were also collected before serum withdrawal (proliferating cells). The samples 
were then fixed with methanol/acetone (1:1), and the distribution of NMIβ was assessed by performing an indirect immunofluorescence assay for 
NMIβ. Images in (a, c) display the distribution of NMIβ in proliferating cells, whereas those in (d and f) show the distribution of NMIβ after 0, 24, 36 and 
48 hours after restimulation of quiescent fibroblasts. The table (p) displays the percentage of cells displaying various patterns of NMIβ staining after 
restimulation. Error is indicated by standard deviation. Scale bar = 10 μm.
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either with 10 mmol/L 2,3-butanedione 2-monoxime
(Calbiochem) for 15 minutes [65-67] or 1 μmol/L Jas-
plakinolide (Calbiochem) for 60 minutes [68]. See Addi-
tional file 5.
Fluorescence in situ hybridization
For the two-dimensional FISH assay, fibroblasts were har-
vested and placed in hypotonic buffer (0.075 mol/L KCl,
wt/vol) for 15 minutes at room temperature. After cen-
trifugation at 400 g, cells were fixed in 3:1 (vol/vol) meth-
anol/acetic acid (vol/vol) for 1 hour on ice. The fixation
step was repeated between 5 and 7 times before cells were
dropped onto humidified glass microscope slides. The
slides were aged at room temperature for 2 days or for an
hour at 70°C before being subjected to dehydration
through an ethanol series of 70%, 90%, and 100%, for 5
minutes each. The cells were denatured in 70% forma-
mide, 2 × sodium saline citrate buffer (SSC), pH 7, at 70°C
for 2 minutes. After denaturation, the slides were imme-
diately plunged into ice-cold 70% ethanol for 5 minutes
and then taken through the ethanol series and air-dried.
For three-dimensional FISH assay, fibroblasts were
washed in 1 × PBS and then fixed in 4% paraformalde-
hyde (wt/vol) in 1 × PBS for 10 minutes. The cells were
then permeabilized with 0.5% Triton-X100 (vol/vol) and
0.5% saponin (wt/vol) in 1 × PBS solution for 20 minutes.
The cells were then incubated in 20% glycerol, 1 × PBS
solution for at least 30 minutes before being snap-frozen
in liquid nitrogen. The cells were repeatedly frozen and
thawed for up to 5 times. After the freeze/thaw cycles, the
cells were then washed in 1 × PBS for at least 30 minutes
and then incubated in 0.1 N HCl for 10 minutes for
depurination. The cells were then washed in 2 × SSC for
15 minutes, with three changes of the buffer, and incu-
bated in 50% formamide, 2 × SSC, at pH 7.0, overnight.
For denaturation, cells were incubated at 73°C to 76°C in
70% formamide, 2 × SSC, pH 7 solution for 3 minutes and
then were immediately transferred to 50% formamide, 2 ×
SSC, pH 7 solution for 1 minute at the same temperature.
Chromosome paints for HSA 10, 13, 18, and X were
amplified from flow-sorted whole-chromosome tem-
plates and labelled with biotin-dUTP by DOP-PCR [69].
The 200- to 400-μg chromosome paints, 7 μg of C0t-1
DNA, and 3 μg of herring sperm were used per slide. All
other chromosome territories were delineated with
directly labelled whole human chromosome paints
(Qbiogene, Cambridge, UK). Probes were denatured at
70°C for 10 minutes with reannealing of repetitive
sequences at 37°C for 30 to 120 minutes. Hybridization
was performed in a humified chamber for 18 to 24 hours
at 37°C. The slides were washed in three changes of 50%
formamide, 2 × SSC, pH 7, at 45°C over a 15-minute
period, followed by three changes of 0.1 × SSC pre-
warmed to 60°C over a 15-minute period at 45°C.
The slides were then transferred to 4 × SSC at room
temperature. Slides hybridized with the in-house biotin-
labelled probes were then incubated with a blocking solu-
tion of 4% bovine serum albumin (BSA; Sigma Aldrich) of
4 × SSC followed by detection with streptavidin-cyanine
3 (Amersham Life Science Ltd; 1:200 dilution in 0.1%
BSA/4 × SSC). The slides were washed in three changes
of 4 × SSC/0.05% Tween 20 (vol/vol) for 5 minutes each.
Suppressing the expression of nuclear myosin 1β by 
interference RNA
To suppress nuclear myosin 1β expression, young prolif-
erating HDFs were seeded at 1 × 104 cells per well in a 12-
well plate. Transfection efficiency was previously deter-
mined with siGLO-labelled siRNA to be more than 95%.
The siRNA transfection was carried out with 2 μl Dhar-
mafect 1 and 50 μl of either negative control (2 μmol/L
ON-TARGETplus Non-targeting Pool; Thermo Scien-
tific) or myosin-targeting siRNA (2 μmol/L ON-TAR-
GETplus SMART pool, human MYO1C; Thermo
Scientific Cat number L-015121-00) in 200 μl serum-free
medium. Complete medium was added to the transfec-
tion mix to ensure that transfections were carried out in
serum-containing medium with a final siRNA concentra-
tion of 100 nmol/L per well/dish. Six hours after transfec-
tion, the medium in the well was replaced with normal
growth medium. At 24 hours after the first transfection, a
second identical transfection was performed to increase
the amount of suppression. Samples were collected at 48
hours after final transfection and fixed for 2D FISH and
indirect immunofluorescence.
Indirect immunofluorescence
Diluted rabbit anti-Ki-67 antibody (Dako; 1:1,500 dilu-
tion in PBS/1% NCS), 40 μl, was placed on the slides after
FISH for 1 hour at 37°C. Slides were washed in PBS for 15
minutes, with three changes. The slides were incubated
with 40 μl of swine anti-rabbit secondary antibody conju-
gated either to fluorescein isothiocynate (FITC, Dako) or
to tetrarhodamine isothiocynate (TRITC, Dako) (1:30
dilution in 1% NCS/PBS) for 1 hour at 37°C.
For anti-nuclear myosin 1β staining, cells were grown
on glass coverslips and fixed in 1:1 (vol/vol) methanol/
acetone for 10 minutes on ice. Rabbit anti-NM1β (Sigma-
Aldrich) was diluted in PBS/1% NCS (1:200) and incu-
bated with the fixed cells at room temperature for 1 hour
after washing thrice in PBS swine anti-rabbit conjugated
to tetrarhodamine isothiocyanate was incubated for 1
hour at room temperature.
Thereafter the slides were washed in PBS with three
changes over a 15-minute period and mounted in self-
sealing Vectashield mounting medium (Vector Laborato-
ries) containing the counterstain 4, 6-diamidino-2-phe-Mehta et al. Genome Biology 2010, 11:R5
http://genomebiology.com/2010/11/1/R5
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nylindole (DAPI).
Image capture and analysis
Two-dimensional FISH
Digital grey-scale images of random nuclei were captured
by using a Photometrics cooled charged-coupled device
(CCD) camera, pseudocolored, and merged by using Dig-
ital Scientific software, the Quips Pathvysion, Smart Cap-
ture VP V1.4, a Leica fluorescence microscope (Leitz
DMRB) with Plan Fluotar 100 × oil-immersion lens. The
images were run through a simple erosion script in IPLab
spectrum software, as described in [4]. The DAPI image
of the nucleus is outlined and divided into five concentric
shells of equal area, the first shell being most peripheral,
and the innermost denoting the interior of the nucleus.
The script measures the pixel intensity of DAPI and the
chromosome probe in these five shells. The probe signal
was normalized by dividing the percentage of the probe
by  t he  pe r c e n ta ge  o f  D API s igna l in eac h s he l l.  Hist o-
grams were plotted with standard error bars representing
the standard error of the mean (± SEM). Simple statistical
analyses were performed by using the unpaired two-
tailed Student's t test with Microsoft Excel.
Three-dimensional FISH
The images of nuclei prepared by three-dimensional
FISH were captured by using a Nikon confocal laser scan-
ning microscope (TE2000-S) equipped with a 60 ×/1.49
Nikon Apo oil-immersion objective. The microscope was
c o n t r o l l e d  b y  N i k o n  c o n f o c a l  m i c r o s c o p e  C 1  ( E Z - C 1 )
software, version 3.00. Stacks of optical sections with an
axial distance of 0.2 μm were collected from 20 random
n u c l e i .  S t a c k s  o f  e i g h t - b i t  g r e y - s c a l e  2 D  i m a g e s  w e r e
obtained with a pixel dwell of 4.56, and eight averages
were taken for each optical image. The positioning of
chromosomes in relation to the nuclear periphery was
assessed by performing measurements with Imaris Soft-
ware (Bitplane Scientific Solutions), whereby the distance
in micrometers between the geometric center of each
chromosome territory and the nearest nuclear periphery,
as determined with DAPI staining, in three dimensions.
These data were not normalized for size, but when the
data were normalized by dividing by the length of the
major axis + the length of the minor axis divided by 2, or
the length of the major axis alone, the relative positions of
the individual chromosomes in frequency distributions
did not change.
Frequency distribution curves were plotted with the
distance between the geometric center of chromosome
territory and the nearest nuclear periphery on the x-axis
in actual micrometers, and the frequency, on the y-axis.
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